Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI

NCT02877927 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

735

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections
Skin Structures and Soft Tissue Infections

Interventions

DRUG: Omadacycline
DRUG: Linezolid

Sponsor

Paratek Pharmaceuticals Inc